Aller au contenu principal
Profil bibliographique

Andres Ferbér

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

48Publications signalées
1901Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Chronic Lymphocytic Leukemia ResearchGrowth Hormone and Insulin-like Growth FactorsLymphoma Diagnosis and TreatmentHematopoietic Stem Cell TransplantationViral-associated cancers and disorders

Les publications récentes

2026 article OpenAlex

Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy

Daan Dierickx, Joosje H. Heimovaara, Mar Bellido, Kristel Van Calsteren et autres

The diagnosis and treatment of hematologic malignancies has undergone significant advancements over the past few decades, resulting in enhanced outcomes. For hematologic malignancies diagnosed during pregnancy, this poses new questions. As possibilities continue to expand and the rising global incidence results in …

be, nl, us, mx, it, pl, dk, de (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature

Soumya Mikkilineni, Juan Pineda-Reyes, Lindsay R. Wilde, Andres Ferbér et autres

The MECOM (MDS1 and EVI1 complex locus) gene, located at 3q26.2, encodes an oncogenic transcription factor implicated in multiple signaling pathways. Rearrangements involving MECOM/3q26.2, including inversions, translocations, insertions and cryptic chromosomal changes, are observed in myeloid neoplasms and are associated with high-risk …

us, it (code pays fourni par la source)

1 citation Frontiers in Oncology
Accès ouvert 2024 article OpenAlex

Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Ramsay Hafer, Francesco Iadevaia, Thomas Z. Rohan, Maria L. Poluch et autres

Bruton tyrosine kinase (BTK) inhibitors (BTKis) have transformed the treatment landscape of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma, the most prevalent form of leukemia in adults. 1 However, the clinical benefit of ibrutinib is accompanied by several side effects and treatmentrelated toxicities.2,3 …

us, it (code pays fourni par la source)

2 citations Blood Neoplasia
Accès ouvert 2024 article OpenAlex

Results of an international survey on the current organization of care for pregnant women with cancer

Joosje H. Heimovaara, Kristel Van Calsteren, Christianne A. R. Lok, Andrew M. Evens et autres

The global incidence of cancer is increasing, including its incidence in women of reproductive age. Still, physicians encounter this situation rarely, which could lead to substandard care. This research sought to explore opportunities to improve future care for pregnant women with cancer, …

nl, be, us, ve, br (code pays fourni par la source)

3 citations Acta Obstetricia Et Gynecologica Scandinavica
2023 conference-abstract OpenAlex

Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas

Nicholas D. Kendsersky, Rebecca Masel, Amman Bhasin, Tingting Zhan et autres

Background: Anti-CD-20 immunochemotherapy with cytotoxic agents has been the traditional front-line therapy for patients with the advanced stage indolent non-Hodgkin lymphomas (iNHL) such as follicular (FL) and marginal zone lymphoma (MZL) requiring treatment. For patients with medical comorbidities and advanced age at …

us (code pays fourni par la source)

0 citations Blood
Accès ouvert 2020 article OpenAlex

Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature

Shreyans Gandhi, Eric M. Behling, Danielle Smith Behrens, Andres Ferbér et autres

The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that have wide variety of clinical and histological presentations. The management of PTLDs is challenging due to variety of involvement sites and histological types. The length and type of immunosuppression are …

us (code pays fourni par la source)

6 citations Case Reports in Transplantation
Accès ouvert 2018 article OpenAlex

A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide

Mamatha Siricilla, Lydia Irwin, Andres Ferbér

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a subtype of nonclassical Hodgkin lymphoma (HL). It resembles non-Hodgkin lymphoma (NHL), by expressing classic B cell markers such as CD20 and CD79a however lacks definitive HL markers (such as CD15 and CD30). T cell …

us (code pays fourni par la source)

2 citations Case Reports in Oncological Medicine
2014 article OpenAlex

Hypernatremia in Acute Myeloid Leukemia With Trisomy 13: A Case Report and Review of Literature of Diabetes Insipidus in Association With Acute Myeloid Leukemia

Kamyar Nader, Nicole Abel, Peter Georges, Chady Abboud-Leon et autres

Diabetes insipidus (DI) is a disorder characterized by the inability of the body to conserve water. It occurs either via a central mechanism, where anti-diuretic hormone (ADH) is deficient, or via a nephrogenic mechanism characterized by normal ADH secretion and varying degrees …

us (code pays fourni par la source)

0 citations Journal of Hematology
2014 article OpenAlex

Iatrogenic lymphoproliferative disorder

Kamyar Nader, Danielle Smith Behrens, Chady Abboud Leon, Roland Schwarting et autres

A 69-year-old male with rheumatoid arthritis, on methotrexate and plaquenil, presented with palpable right axillary lymphadenopathy. This was associated with progressive dyspnea, weight loss, and night-sweats for one-month duration. On examination, there was a 2 × 2 cm nontender lymph node on …

us (code pays fourni par la source)

0 citations American Journal of Hematology
2014 article OpenAlex

Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.

Kamyar Nader, Shaffer R. S. Mok, Ankur Kalra, Antoine Joseph Harb et autres

Vanishing bile duct syndrome (VBDS) is characterized by cholestasis and progressive destruction of the intrahepatic bile ducts (ductopenia). The current definition of ductopenia is the loss of interlobular bile ducts in more than 50% of portal tracts. Ductopenia is believed, at a …

us (code pays fourni par la source)

13 citations PubMed
2013 article OpenAlex

Brentuximab Vedotin: A Promising Therapeutic Option In An HIV Patient With Advanced Hodgkin lymphoma and Significant Hyperbilirubinemia From Liver Involvement

Peter Georges, Chady Abboud Leon, Linda Devereux, Andres Ferbér

Abstract Case report A 54-year-old male with AIDS based on a CD4 count of 48, and viral load of 71653 IU/ml was admitted to our institution for evaluation of ongoing fevers, chills, night sweats, and pancytopenia. His evaluation included a bone marrow …

us (code pays fourni par la source)

2 citations Blood
2013 article OpenAlex

Vanishing Bile Duct Syndrome as a Manifestation of Hodgkin's Lymphoma: A Case Report and Review of the Literature

Kamyar Nader, Shaffer R. S. Mok, Ankur Kalra, Antoine Joseph Harb et autres

Vanishing bile duct syndrome (VBDS) is characterized by cholestasis and progressive destruction of the intrahepatic bile ducts (ductopenia). The current definition of ductopenia is the loss of interlobular bile ducts in more than 50% of portal tracts. Ductopenia is believed, at a …

us (code pays fourni par la source)

21 citations Tumori Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.